Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,365 results for ""NUCLEOSIDE reverse transcriptase inhibitors""

Your Filters

Content Provider : Gale In Context
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study.

  • Source: BMC Infectious Diseases. October 7, 2021, Vol. 21 Issue 1.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study.

  • Source: BMC Infectious Diseases. October 25, 2021, Vol. 21 Issue 1.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.

  • Source: PLoS ONE. July 21, 2021, Vol. 16 Issue 7, e0253861.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.

  • Source: PLoS ONE. November 23, 2020, Vol. 15 Issue 11, e0242405.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.

  • Source: PLoS ONE. October 13, 2016, Vol. 11 Issue 10, e0162775.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells.

  • Source: PLoS ONE. June 18, 2015, Vol. 10 Issue 6.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Induction with Lopinavir-Based Treatment Followed by Switch to Nevirapine-Based Regimen versus Non-Nucleoside Reverse Transcriptase Inhibitors-Based Treatment for First Line Antiretroviral Therapy in HIV Infected Children Three Years and Older.

  • Source: PLoS ONE. September 18, 2014, Vol. 9 Issue 9.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

  • Source: BMC Infectious Diseases. July 21, 2014, Vol. 14.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs.

  • Source: PLoS ONE. November 15, 2012, Vol. 7 Issue 11, e47505.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.

  • Source: PLoS ONE. November 26, 2012, Vol. 7 Issue 11, e50307.

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  1,365 results for ""NUCLEOSIDE reverse transcriptase inhibitors""